These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36303046)

  • 41. Effects of calcium-containing phosphate binders on cardiovascular events and mortality in predialysis CKD stage 5 patients.
    Tsai PH; Chung CH; Chien WC; Chu P
    PLoS One; 2020; 15(10):e0241435. PubMed ID: 33125428
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Tentori F; Blayney MJ; Albert JM; Gillespie BW; Kerr PG; Bommer J; Young EW; Akizawa T; Akiba T; Pisoni RL; Robinson BM; Port FK
    Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mild hyperphosphatemia and mortality in hemodialysis patients.
    Rodriguez-Benot A; Martin-Malo A; Alvarez-Lara MA; Rodriguez M; Aljama P
    Am J Kidney Dis; 2005 Jul; 46(1):68-77. PubMed ID: 15983959
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dietary interventions for mineral and bone disorder in people with chronic kidney disease.
    Liu Z; Su G; Guo X; Wu Y; Liu X; Zou C; Zhang L; Yang Q; Xu Y; Ma W
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD010350. PubMed ID: 26376110
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of hyperphosphatemia: the dangers of aiming for normal PTH levels.
    Haffner D; Leifheit-Nestler M
    Pediatr Nephrol; 2020 Mar; 35(3):485-491. PubMed ID: 31823044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiovascular Outcomes of Calcium-Free vs Calcium-Based Phosphate Binders in Patients 65 Years or Older With End-stage Renal Disease Requiring Hemodialysis.
    Spoendlin J; Paik JM; Tsacogianis T; Kim SC; Schneeweiss S; Desai RJ
    JAMA Intern Med; 2019 Jun; 179(6):741-749. PubMed ID: 31058913
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between serum fibroblast growth factor-23 level and mortality in chronic hemodialysis patients.
    Sugimoto H; Ogawa T; Iwabuchi Y; Otsuka K; Nitta K
    Int Urol Nephrol; 2014 Jan; 46(1):99-106. PubMed ID: 23355029
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Wasting and sudden cardiac death in hemodialysis patients: a post hoc analysis of 4D (Die Deutsche Diabetes Dialyse Studie).
    Drechsler C; Grootendorst DC; Pilz S; Tomaschitz A; Krane V; Dekker F; März W; Ritz E; Wanner C
    Am J Kidney Dis; 2011 Oct; 58(4):599-607. PubMed ID: 21820222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between the risk of death and serum calcium, phosphate, and intact parathyroid hormone levels in older patients undergoing maintenance hemodialysis: a cohort study in Beijing.
    Li D; Liu W; Huang H; Guo W; Diao Z; Chen X; Wangs W
    Ther Adv Endocrinol Metab; 2021; 12():20420188211025161. PubMed ID: 34262687
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of mineral content outside of bone with coronary artery calcium and 1-year cardiovascular prognosis in maintenance hemodialysis patients.
    Xiong Y; Li J; Sun S; Han M; Liao R; Li Y; Wang L; Lin L; Liu Q; Su B
    Artif Organs; 2019 Oct; 43(10):988-1001. PubMed ID: 30932185
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mineral and bone disorders in conventional hemodialysis: Challenges and solutions.
    Hamano T
    Semin Dial; 2018 Nov; 31(6):592-598. PubMed ID: 29900589
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trabecular bone score may indicate chronic kidney disease-mineral and bone disorder (CKD-MBD) phenotypes in hemodialysis patients: a prospective observational study.
    Yun HJ; Ryoo SR; Kim JE; Choi YJ; Park I; Shin GT; Kim H; Jeong JC
    BMC Nephrol; 2020 Jul; 21(1):299. PubMed ID: 32711466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison between calcitriol and calcitriol plus low-dose cinacalcet for the treatment of moderate to severe secondary hyperparathyroidism in chronic dialysis patients.
    Lee YT; Ng HY; Kuo CC; Chen TC; Wu CS; Chiu TT; Lee WC; Lee CT
    Nutrients; 2013 Apr; 5(4):1336-48. PubMed ID: 23603995
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) Study.
    Wald R; Sarnak MJ; Tighiouart H; Cheung AK; Levey AS; Eknoyan G; Miskulin DC
    Am J Kidney Dis; 2008 Sep; 52(3):531-40. PubMed ID: 18657891
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hidden Hypocalcemia as a Risk Factor for Cardiovascular Events and All-Cause Mortality among Patients Undergoing Incident Hemodialysis.
    Yamaguchi S; Hamano T; Doi Y; Oka T; Kajimoto S; Kubota K; Yasuda S; Shimada K; Matsumoto A; Hashimoto N; Sakaguchi Y; Matsui I; Isaka Y
    Sci Rep; 2020 Mar; 10(1):4418. PubMed ID: 32157180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The cardiothoracic ratio and all-cause and cardiovascular disease mortality in patients undergoing maintenance hemodialysis: results of the MBD-5D study.
    Ogata H; Kumasawa J; Fukuma S; Mizobuchi M; Kinugasa E; Fukagawa M; Fukuhara S; Akizawa T
    Clin Exp Nephrol; 2017 Oct; 21(5):797-806. PubMed ID: 28508128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of morbidity and mortality data related to cardiovascular calcification from calcium-containing phosphate binder use in patients undergoing hemodialysis.
    Mason MA; Shepler BM
    Pharmacotherapy; 2010 Jul; 30(7):741-8. PubMed ID: 20575637
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mineral Metabolism Markers Are Associated with Myocardial Infarction and Hemorrhagic Stroke but Not Ischemic Stroke in Hemodialysis Patients: A Longitudinal Study.
    Tagawa M; Hamano T; Nishi H; Tsuchida K; Hanafusa N; Fukatsu A; Iseki K; Tsubakihara Y
    PLoS One; 2014; 9(12):e114678. PubMed ID: 25494334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of serum globulin with all-cause mortality in incident hemodialysis patients.
    Pai AY; Sy J; Kim J; Kleine CE; Edward J; Hsiung JT; Kovesdy CP; Kalantar-Zadeh K; Streja E
    Nephrol Dial Transplant; 2022 Sep; 37(10):1993-2003. PubMed ID: 34617572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypophosphatemia: nutritional status, body composition, and mortality in hemodialysis patients.
    Garagarza C; Valente A; Caetano C; Oliveira T; Ponce P; Silva AP
    Int Urol Nephrol; 2017 Jul; 49(7):1243-1250. PubMed ID: 28265965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.